Clinical trial · Interventional
Mantle Irradiation for Hodgkin's Disease
Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease
NCT00165269CI-TRIAL-00002757completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkin's disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hodgkin's Disease | Hodgkin Lymphoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mantle irradiation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To evaluate the risks and benefits of mantle field irradiation alone in treating Hodgkin disease patients.
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pathologically Stage IA-IIA Hodgkin's disease * A negative staging laparotomy including splenectomy, biopsies of liver, paraortic nodal biopsies and palpitation of upper pelvic nodes * 18 years of age or older Exclusion Criteria: * Patients with large mediastinal adenopathy * Patients with LD histology * Patients with "B" symptoms * Positive laparotomy * Subcarinal, hilar, or cardiac lymph node involvement
References
Publications (0)
Data not yet available
No reference posted for this study.